Rigel Pharma (RIGL) Reports In-Line Q1 EPS, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 47.68 -1.18 (2.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.86 | 52 Week High | $4.38 | |||
| Open | $48.48 | 52 Week Low | $1.88 | |||
| Day High | $48.48 | P/E | N/A | |||
| Day Low | $47.47 | EPS | $-1.12 | |||
| Volume | 47,627 | |||||
